Exenatide improves weight loss insulin sensitivity and β-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy. (Q44384098)
Jump to navigation
Jump to search
scientific article published on 8 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Exenatide improves weight loss insulin sensitivity and β-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy. |
scientific article published on 8 June 2011 |
Statements
Exenatide improves weight loss insulin sensitivity and β-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy (English)
M P Hermans
P Selvais
M Buysschaert
X de la Tribonnière